These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


251 related items for PubMed ID: 20523105

  • 1. Effects of silibinin, inhibitor of CYP3A4 and P-glycoprotein in vitro, on the pharmacokinetics of paclitaxel after oral and intravenous administration in rats.
    Lee CK, Choi JS.
    Pharmacology; 2010; 85(6):350-6. PubMed ID: 20523105
    [Abstract] [Full Text] [Related]

  • 2. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats.
    Li X, Choi JS.
    Int J Pharm; 2007 Jun 07; 337(1-2):188-93. PubMed ID: 17267149
    [Abstract] [Full Text] [Related]

  • 3. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats.
    Choi BC, Choi JS, Han HK.
    Int J Pharm; 2006 Oct 12; 323(1-2):81-5. PubMed ID: 16806758
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of silybinin, CYP3A4 and P-glycoprotein inhibitor in vitro, on the bioavailability of loratadine in rats.
    Li C, Lee MY, Choi JS.
    Pharmazie; 2010 Jul 12; 65(7):510-4. PubMed ID: 20662320
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin.
    Cho YA, Lee W, Choi JS.
    Pharmazie; 2012 Feb 12; 67(2):124-30. PubMed ID: 22512082
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of oral bioavailability of paclitaxel after oral administration of Schisandrol B in rats.
    Jin J, Bi H, Hu J, Zhong G, Zhao L, Huang Z, Huang M.
    Biopharm Drug Dispos; 2010 May 12; 31(4):264-8. PubMed ID: 20437465
    [Abstract] [Full Text] [Related]

  • 9. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo.
    Varma MV, Panchagnula R.
    Eur J Pharm Sci; 2005 May 12; 25(4-5):445-53. PubMed ID: 15890503
    [Abstract] [Full Text] [Related]

  • 10. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
    Hendrikx JJ, Lagas JS, Rosing H, Schellens JH, Beijnen JH, Schinkel AH.
    Int J Cancer; 2013 May 15; 132(10):2439-47. PubMed ID: 23090875
    [Abstract] [Full Text] [Related]

  • 11. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
    Li X, Choi JS.
    Anticancer Res; 2009 Apr 15; 29(4):1411-5. PubMed ID: 19414395
    [Abstract] [Full Text] [Related]

  • 12. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats.
    Li C, Li X, Choi JS.
    Arch Pharm Res; 2009 Jan 15; 32(1):133-8. PubMed ID: 19183886
    [Abstract] [Full Text] [Related]

  • 13. Effects of morin on the pharmacokinetics of etoposide in rats.
    Li X, Yun JK, Choi JS.
    Biopharm Drug Dispos; 2007 Apr 15; 28(3):151-6. PubMed ID: 17315145
    [Abstract] [Full Text] [Related]

  • 14. P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel.
    Kimura Y, Aoki J, Kohno M, Ooka H, Tsuruo T, Nakanishi O.
    Cancer Chemother Pharmacol; 2002 Apr 15; 49(4):322-8. PubMed ID: 11914912
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.
    Bardelmeijer HA, Beijnen JH, Brouwer KR, Rosing H, Nooijen WJ, Schellens JH, van Tellingen O.
    Clin Cancer Res; 2000 Nov 15; 6(11):4416-21. PubMed ID: 11106262
    [Abstract] [Full Text] [Related]

  • 18. The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles.
    Mo R, Jin X, Li N, Ju C, Sun M, Zhang C, Ping Q.
    Biomaterials; 2011 Jul 15; 32(20):4609-20. PubMed ID: 21440934
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges.
    Torne SJ, Ansari KA, Vavia PR, Trotta F, Cavalli R.
    Drug Deliv; 2010 Aug 15; 17(6):419-25. PubMed ID: 20429848
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.